Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
UBS
Daiichi Sankyo
Chinese Patent Office
Harvard Business School
Baxter
AstraZeneca
McKinsey

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CEFTAROLINE FOSAMIL

« Back to Dashboard

Clinical Trials for Ceftaroline Fosamil

Trial ID Title Status Sponsor Phase Summary
NCT00633126 Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age Completed Forest Laboratories Phase 1 The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects
NCT00633152 Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections Completed Forest Laboratories Phase 2 The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin and skin structure infections in adults.
NCT01281462 Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections Completed Forest Laboratories Phase 2 This is a study in adult subjects with complicated urinary tract infection (cUTI) comparing treatment with intravenous (IV) coadministered ceftaroline fosamil and NXL104 versus treatment with IV doripenem.
NCT01290900 A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Completed AstraZeneca Phase 1 This is a single dose study in healthy male volunteers to investigate the effect of high doses of ceftazidime NXL104 (CAZ104) or ceftaroline fosamil NXL104 (CXL104) on the QT interval
NCT01298843 Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital Completed Forest Laboratories Phase 4 The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.
NCT01400867 Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections Completed AstraZeneca Phase 2/Phase 3 This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.
NCT01400867 Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections Completed Forest Laboratories Phase 2/Phase 3 This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ceftaroline Fosamil

Condition Name

Condition Name for Ceftaroline Fosamil
Intervention Trials
Infections 4
Healthy 2
Osteomyelitis 2
Complicated Skin and Soft Tissue Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ceftaroline Fosamil
Intervention Trials
Infection 9
Communicable Diseases 7
Pneumonia 6
Pneumonia, Bacterial 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ceftaroline Fosamil

Trials by Country

Trials by Country for Ceftaroline Fosamil
Location Trials
United States 124
Poland 6
Greece 6
Spain 6
Argentina 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ceftaroline Fosamil
Location Trials
California 11
Ohio 10
Texas 9
Florida 8
Michigan 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ceftaroline Fosamil

Clinical Trial Phase

Clinical Trial Phase for Ceftaroline Fosamil
Clinical Trial Phase Trials
Phase 4 7
Phase 3 3
Phase 2/Phase 3 3
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ceftaroline Fosamil
Clinical Trial Phase Trials
Completed 20
Recruiting 5
Withdrawn 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ceftaroline Fosamil

Sponsor Name

Sponsor Name for Ceftaroline Fosamil
Sponsor Trials
Forest Laboratories 20
AstraZeneca 12
Basim Asmar 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ceftaroline Fosamil
Sponsor Trials
Industry 33
Other 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
Fuji
Daiichi Sankyo
McKesson
QuintilesIMS
Harvard Business School
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.